Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

clear all | select all

Conference Years:

clear all | select all

Days Within Meeting:

clear all | select all

Conferences:

Availability:

clear all | select all

Participation Type:

clear all | select all

Topic Tracks*:

clear all | select all

Organ Site Tracks*:

Showing session: reset

Plenary Session 2: From Glues to ‘TACs-- Re-directing Cellular Protein Degradation

  • Sort by:
  • Browse by:
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 3 of 3
Plenary Session 2: From Glues to ‘TACs-- Re-directing Cellular Protein Degradation
Targeted Protein Degradation as a new Approach to Cancer Drugs
Nathanael S Gray
Dana-Farber Cancer Institute, Boston, MA, United States
from 2019 Molecular Targets and Cancer Therapeutics conference on October 27, 2019 10:00 AM-11:45 AM
Plenary Session 2: From Glues to ‘TACs-- Re-directing Cellular Protein Degradation
Exploiting E3 ligases for target validation and drug discovery: What have we learnt so far?
Rajesh Chopra
The Institute of Cancer Research, London, United Kingdom
from 2019 Molecular Targets and Cancer Therapeutics conference on October 27, 2019 10:00 AM-11:45 AM
Plenary Session 2: From Glues to ‘TACs-- Re-directing Cellular Protein Degradation
  •  
  • Free
  • Coming soon
  • Some slides withheld
  •  
  •  
The zinc-finger degrome
Nicolas H. Thoma
Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland
from 2019 Molecular Targets and Cancer Therapeutics conference on October 27, 2019 10:00 AM-11:45 AM
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 3 of 3